Therapeutic Guidelines for the Treatment of Bone Metastasis: A Report from the American College of Radiology Appropriateness Criteria Expert Panel on Radiation Oncology

被引：96

作者：

Janjan, Nora ^{[1
]}

Lutz, Stephen T. ^{[2
]}

Bedwinek, John M. ^{[3
]}

Hartsell, William F. ^{[4
]}

Ng, Andrea ^{[5
]}

Pieters, Richard S., Jr. ^{[6
]}

Ratanatharathorn, Vaneerat ^{[7
]}

Silberstein, Edward B. ^{[8
]}

Taub, Robert J. ^{[9
]}

Yasko, Alan W. ^{[10
]}

Rettenmaier, Andrew ^{[11
,12
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[2] Blanchard Valley Reg Canc Ctr, Findlay, OH USA

[3] Missouri Canc Care, Wentzville, MO USA

[4] Good Samaritan Canc Ctr, Downers Grove, IL USA

[5] Harvard Univ, Boston, MA 02115 USA

[6] Umass Mem Med Ctr, Worcester, MA USA

[7] Univ Arkansas Med Sci, Little Rock, AR 72205 USA

[8] Soc Nucl Med, EL Saenger Radioisotope Lab, Cincinnati, OH USA

[9] Amer Soc Clin Oncol, Cedars Sinai Hosp Program, Los Angeles, CA USA

[10] Amer Acad Orthopaed Surg, MED Orthoped Surg, Chicago, IL USA

[11] Texas A&M Univ, Dept Econ, College Stn, TX 77843 USA

[12] Texas A&M Univ, Private Enterprise Res Ctr, College Stn, TX USA

来源：

JOURNAL OF PALLIATIVE MEDICINE | 2009年 / 12卷 / 05期

关键词：

DIAMINE TETRAMETHYLENE PHOSPHONATE; PROSPECTIVE RANDOMIZED-TRIAL; SINGLE FRACTION; PROSTATE-CANCER; BREAST-CANCER; MULTIFRACTION RADIOTHERAPY; PROGNOSTIC-SIGNIFICANCE; SKELETAL IRRADIATION; LOW TOXICITY; PAIN RELIEF;

D O I：

10.1089/jpm.2009.9633

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

100404 [儿少卫生与妇幼保健学];

摘要：

Bone metastases remain a therapeutic challenge because of the diversity of the problems they cause, the relative paucity of data regarding their treatment, and the necessity for management by a multidisciplinary palliative care team. The American College of Radiology convened an Appropriateness Criteria Expert Panel on Radiation Oncology for the treatment of bone metastasis to create representative clinical case scenarios and then rank the appropriate use of treatment modalities as well as the most reasonable radiotherapy dose schema and treatment planning methods. Here we present both the resulting Appropriateness Criteria and the rationale for making these decisions. The treatment recommendations are placed within the larger framework of the role of radiation in palliative care by discussing the efficiency of palliative radiotherapy schedules, cost effectiveness issues, and the need for additional research regarding the proper multidisciplinary care of patients with symptomatic bone metastasis.

引用

页码：417 / 426

页数：10

共 51 条

[1]

Dose response relationship and multiple dose efficacy and toxicity of samarium-153-EDTMP in metastatic cancer to bone [J].

Alberts, AS ;

Smit, BJ ;

Louw, WKA ;

vanRensburg, AJ ;

vanBeek, A ;

Kritzinger, V ;

Nel, JS .

RADIOTHERAPY AND ONCOLOGY, 1997, 43 (02) :175-179

[2]

High-dose samarium-153 ethylene diamine tetramethylene phosphonate: Low toxicity of skeletal irradiation in patients with osteosarcoma and bone metastases [J].

Anderson, PM ;

Wiseman, GA ;

Dispenzieri, A ;

Arndt, CAS ;

Hartmann, LC ;

Smithson, WA ;

Mullan, BP ;

Bruland, OS .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (01) :189-196

[3]

[Anonymous], 1999, Radiother Oncol, V52, P111, DOI 10.1016/S0167-8140(99)00097-3

[4]

[Anonymous], J BRACHYTHERAPY INT

[5]

THE PALLIATIVE EFFICACY OF A SINGLE HIGH-DOSE OF RADIATION IN TREATMENT OF SYMPTOMATIC OSSEOUS METASTASES [J].

BARAK, F ;

WERNER, A ;

WALACH, N ;

HORN, Y .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1987, 13 (08) :1233-1235

[6]

BLITZER PH, 1985, CANCER-AM CANCER SOC, V55, P1468, DOI 10.1002/1097-0142(19850401)55:7<1468::AID-CNCR2820550708>3.0.CO

[7]

2-M

[8]

BOLGER JJ, 1993, SEMIN ONCOL, V20, P32

[9]

A single fraction for all, or an argument for fractionation tailored to fit the needs of each individual patient with bone metastases? [J].

Chow, E ;

Lutz, S ;

Beyene, J .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 55 (03) :565-567

[10]

Cole D J, 1989, Clin Oncol (R Coll Radiol), V1, P59, DOI 10.1016/S0936-6555(89)80035-4

← 1 2 3 4 5 6 →